Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Profusa ( (PFSA) ) is now available.
On October 7, 2025, Profusa, Inc. announced its second $1 million investment in digital treasury assets as part of its strategy to hedge against macroeconomic uncertainties, in collaboration with Ascent Partners Fund. This investment is part of a broader effort to maintain sufficient capital for the development and commercialization of its AI-driven digital health platform, which supports chronic disease and health management. Additionally, the company amended its bylaws to reduce the quorum requirement for stockholder meetings and adjourned a special meeting due to insufficient quorum, rescheduling it for October 20, 2025.
More about Profusa
Profusa, Inc., based in Berkeley, California, is a commercial stage digital health company focused on developing tissue-integrated sensors for continuous biochemical monitoring. The company aims to provide actionable, medical-grade data for personal and medical use through its Lumee platform technology.
Average Trading Volume: 9,855,056
Technical Sentiment Signal: Sell
Current Market Cap: $14.37M
For detailed information about PFSA stock, go to TipRanks’ Stock Analysis page.